The Randomized Leipzig Immediate Percutaneous Coronary Intervention Abciximab IV Versus IC in ST-Elevation Myocardial Infarction Trial - Randomized Leipzig Immediate PCI Abciximab IV vs. IC in STEMI Trial


The goal of the trial was to evaluate treatment with intravenous (IV) compared with intracoronary (IC) abciximab in patients with ST-elevation myocardial infarction (STEMI) undergoing percutaneous coronary intervention (PCI).